[Frequently occurring forms of dizziness and their treatment].
Dizziness is not a unique clinical picture, but rather is the unspecific symptom of numerous diseases. Dizziness always develops when the real incoming vestibular, visual and somatosensory information contradict each other and the expected input signals. Disorders of the vestibular apparatus are the most frequent cause of dizziness; in contrast, cervicogenic causes play a secondary role. Dizziness syndromes usually have a favourable prognosis and can be successfully treated.
Thömke
Frank
F
Klinik und Poliklinik für Neurologie der Johannes-Gutenberg-Universität, Mainz. thoemke@neurologie.klinik.uni-mainz.de
D000588:Amines / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D001621:Betahistine / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004244:Dizziness / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000523:psychology / Q000628:therapy; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D000077206:Gabapentin; D006801:Humans; D008279:Magnetic Resonance Imaging; D008559:Memantine / Q000627:therapeutic use; D008575:Meniere Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008875:Middle Aged; D008881:Migraine Disorders / Q000150:complications; D009760:Nystagmus, Physiologic; D013577:Syndrome; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use; D014717:Vertigo / Q000175:diagnosis; D015837:Vestibular Diseases / Q000150:complications; D020338:Vestibular Neuronitis / Q000150:complications; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D018691:Excitatory Amino Acid Antagonists; D014665:Vasodilator Agents; D002220:Carbamazepine; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D008559:Memantine; D001621:Betahistine